nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpromazine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.176	1	CbGbCtD
Chlorpromazine—Asphyxia—Riluzole—amyotrophic lateral sclerosis	0.0589	0.213	CcSEcCtD
Chlorpromazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0168	0.0615	CbGeAlD
Chlorpromazine—Thrombocytopenic purpura—Riluzole—amyotrophic lateral sclerosis	0.0157	0.0571	CcSEcCtD
Chlorpromazine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0153	0.0554	CcSEcCtD
Chlorpromazine—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0124	0.0452	CbGeAlD
Chlorpromazine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00981	0.0356	CcSEcCtD
Chlorpromazine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00911	0.033	CcSEcCtD
Chlorpromazine—Endocrine disorder—Riluzole—amyotrophic lateral sclerosis	0.00891	0.0323	CcSEcCtD
Chlorpromazine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.0084	0.0305	CcSEcCtD
Chlorpromazine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00757	0.0274	CcSEcCtD
Chlorpromazine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.0073	0.0265	CcSEcCtD
Chlorpromazine—CALM1—cranial nerve—amyotrophic lateral sclerosis	0.00718	0.0263	CbGeAlD
Chlorpromazine—CALM2—pons—amyotrophic lateral sclerosis	0.00713	0.0261	CbGeAlD
Chlorpromazine—CALM1—pons—amyotrophic lateral sclerosis	0.0071	0.026	CbGeAlD
Chlorpromazine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00702	0.0257	CbGeAlD
Chlorpromazine—HTR7—pons—amyotrophic lateral sclerosis	0.00694	0.0254	CbGeAlD
Chlorpromazine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00693	0.0251	CcSEcCtD
Chlorpromazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0061	0.0221	CcSEcCtD
Chlorpromazine—DRD1—nerve—amyotrophic lateral sclerosis	0.00576	0.0211	CbGeAlD
Chlorpromazine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00568	0.0206	CcSEcCtD
Chlorpromazine—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00554	0.0201	CcSEcCtD
Chlorpromazine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0185	CcSEcCtD
Chlorpromazine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.0051	0.0185	CcSEcCtD
Chlorpromazine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0049	0.0177	CcSEcCtD
Chlorpromazine—CALM2—peripheral nervous system—amyotrophic lateral sclerosis	0.00475	0.0174	CbGeAlD
Chlorpromazine—CALM1—peripheral nervous system—amyotrophic lateral sclerosis	0.00472	0.0173	CbGeAlD
Chlorpromazine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0168	CcSEcCtD
Chlorpromazine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0168	CcSEcCtD
Chlorpromazine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00463	0.0168	CcSEcCtD
Chlorpromazine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00461	0.0169	CbGeAlD
Chlorpromazine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0044	0.016	CcSEcCtD
Chlorpromazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00438	0.016	CbGeAlD
Chlorpromazine—HTR2A—pons—amyotrophic lateral sclerosis	0.00432	0.0158	CbGeAlD
Chlorpromazine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00427	0.0155	CcSEcCtD
Chlorpromazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00423	0.0153	CcSEcCtD
Chlorpromazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00403	0.0146	CcSEcCtD
Chlorpromazine—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00386	0.59	CrCbGaD
Chlorpromazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00385	0.014	CcSEcCtD
Chlorpromazine—CALM2—nerve—amyotrophic lateral sclerosis	0.0037	0.0135	CbGeAlD
Chlorpromazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00369	0.0135	CbGeAlD
Chlorpromazine—CALM1—nerve—amyotrophic lateral sclerosis	0.00368	0.0135	CbGeAlD
Chlorpromazine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00365	0.0132	CcSEcCtD
Chlorpromazine—HTR7—nerve—amyotrophic lateral sclerosis	0.0036	0.0132	CbGeAlD
Chlorpromazine—DRD2—nerve—amyotrophic lateral sclerosis	0.0034	0.0124	CbGeAlD
Chlorpromazine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00338	0.0124	CbGeAlD
Chlorpromazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00316	0.0116	CbGeAlD
Chlorpromazine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00313	0.0114	CcSEcCtD
Chlorpromazine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0113	CcSEcCtD
Chlorpromazine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00302	0.011	CcSEcCtD
Chlorpromazine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00295	0.0107	CcSEcCtD
Chlorpromazine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0105	CcSEcCtD
Chlorpromazine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00289	0.0105	CcSEcCtD
Chlorpromazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00288	0.0105	CbGeAlD
Chlorpromazine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0103	CcSEcCtD
Chlorpromazine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00282	0.0103	CbGeAlD
Chlorpromazine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00282	0.0102	CcSEcCtD
Chlorpromazine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0101	CcSEcCtD
Chlorpromazine—CALM2—hindbrain—amyotrophic lateral sclerosis	0.00277	0.0101	CbGeAlD
Chlorpromazine—CALM1—hindbrain—amyotrophic lateral sclerosis	0.00276	0.0101	CbGeAlD
Chlorpromazine—SMPD1—spinal cord—amyotrophic lateral sclerosis	0.00271	0.00992	CbGeAlD
Chlorpromazine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00269	0.00986	CbGeAlD
Chlorpromazine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00974	CcSEcCtD
Chlorpromazine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00955	CcSEcCtD
Chlorpromazine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00949	CcSEcCtD
Chlorpromazine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0026	0.00951	CbGeAlD
Chlorpromazine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00259	0.0094	CcSEcCtD
Chlorpromazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00257	0.00932	CcSEcCtD
Chlorpromazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00255	0.00932	CbGeAlD
Chlorpromazine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00247	0.00904	CbGeAlD
Chlorpromazine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00893	CcSEcCtD
Chlorpromazine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00864	CcSEcCtD
Chlorpromazine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00852	CcSEcCtD
Chlorpromazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00234	0.00849	CcSEcCtD
Chlorpromazine—SMPD1—nervous system—amyotrophic lateral sclerosis	0.00228	0.00836	CbGeAlD
Chlorpromazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00817	CcSEcCtD
Chlorpromazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00224	0.00821	CbGeAlD
Chlorpromazine—SMPD1—central nervous system—amyotrophic lateral sclerosis	0.0022	0.00805	CbGeAlD
Chlorpromazine—SMPD1—cerebellum—amyotrophic lateral sclerosis	0.00215	0.00787	CbGeAlD
Chlorpromazine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00755	CcSEcCtD
Chlorpromazine—DRD4—brain—amyotrophic lateral sclerosis	0.00197	0.0072	CbGeAlD
Chlorpromazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00194	0.00704	CcSEcCtD
Chlorpromazine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00192	0.00703	CbGeAlD
Chlorpromazine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00181	0.00662	CbGeAlD
Chlorpromazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.00175	0.267	CrCbGaD
Chlorpromazine—SMPD1—brain—amyotrophic lateral sclerosis	0.00175	0.00639	CbGeAlD
Chlorpromazine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00632	CcSEcCtD
Chlorpromazine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00174	0.00637	CbGeAlD
Chlorpromazine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00174	0.00637	CbGeAlD
Chlorpromazine—CALM2—embryo—amyotrophic lateral sclerosis	0.00173	0.00634	CbGeAlD
Chlorpromazine—CALM1—embryo—amyotrophic lateral sclerosis	0.00172	0.00631	CbGeAlD
Chlorpromazine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00169	0.0062	CbGeAlD
Chlorpromazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00168	0.00615	CbGeAlD
Chlorpromazine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00168	0.00613	CbGeAlD
Chlorpromazine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00163	0.00597	CbGeAlD
Chlorpromazine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00162	0.00591	CbGeAlD
Chlorpromazine—CALM2—brainstem—amyotrophic lateral sclerosis	0.00159	0.00581	CbGeAlD
Chlorpromazine—CALM1—brainstem—amyotrophic lateral sclerosis	0.00158	0.00579	CbGeAlD
Chlorpromazine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00154	0.00565	CbGeAlD
Chlorpromazine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00153	0.0056	CbGeAlD
Chlorpromazine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00149	0.00545	CbGeAlD
Chlorpromazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00146	0.00534	CbGeAlD
Chlorpromazine—CALM3—medulla oblongata—amyotrophic lateral sclerosis	0.00141	0.00516	CbGeAlD
Chlorpromazine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00139	0.00508	CbGeAlD
Chlorpromazine—DRD3—brain—amyotrophic lateral sclerosis	0.00138	0.00506	CbGeAlD
Chlorpromazine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00134	0.0049	CbGeAlD
Chlorpromazine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00134	0.00489	CbGeAlD
Chlorpromazine—HTR6—brain—amyotrophic lateral sclerosis	0.00133	0.00487	CbGeAlD
Chlorpromazine—BCHE—brainstem—amyotrophic lateral sclerosis	0.00132	0.00485	CbGeAlD
Chlorpromazine—DRD5—brain—amyotrophic lateral sclerosis	0.0013	0.00474	CbGeAlD
Chlorpromazine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00129	0.00474	CbGeAlD
Chlorpromazine—CALM3—spinal cord—amyotrophic lateral sclerosis	0.00126	0.0046	CbGeAlD
Chlorpromazine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00125	0.00456	CbGeAlD
Chlorpromazine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00119	0.00437	CbGeAlD
Chlorpromazine—CALM2—medulla oblongata—amyotrophic lateral sclerosis	0.00111	0.00405	CbGeAlD
Chlorpromazine—CALM1—medulla oblongata—amyotrophic lateral sclerosis	0.0011	0.00403	CbGeAlD
Chlorpromazine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00108	0.00394	CbGeAlD
Chlorpromazine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00106	0.00389	CbGeAlD
Chlorpromazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00105	0.00385	CbGeAlD
Chlorpromazine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00104	0.00382	CbGeAlD
Chlorpromazine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00102	0.00375	CbGeAlD
Chlorpromazine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00101	0.00368	CbGeAlD
Chlorpromazine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.001	0.00368	CbGeAlD
Chlorpromazine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.001	0.00368	CbGeAlD
Chlorpromazine—KCNH2—medulla oblongata—amyotrophic lateral sclerosis	0.001	0.00367	CbGeAlD
Chlorpromazine—CALM3—cerebellum—amyotrophic lateral sclerosis	0.000997	0.00365	CbGeAlD
Chlorpromazine—DRD1—brain—amyotrophic lateral sclerosis	0.00099	0.00362	CbGeAlD
Chlorpromazine—CALM2—spinal cord—amyotrophic lateral sclerosis	0.000987	0.00361	CbGeAlD
Chlorpromazine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.000987	0.00361	CbGeAlD
Chlorpromazine—CALM1—spinal cord—amyotrophic lateral sclerosis	0.000983	0.0036	CbGeAlD
Chlorpromazine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.000968	0.00354	CbGeAlD
Chlorpromazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000963	0.00352	CbGeAlD
Chlorpromazine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00096	0.00351	CbGeAlD
Chlorpromazine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00095	0.00348	CbGeAlD
Chlorpromazine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.000945	0.00346	CbGeAlD
Chlorpromazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.000938	0.143	CrCbGaD
Chlorpromazine—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.000923	0.00338	CbGeAlD
Chlorpromazine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.000914	0.00335	CbGeAlD
Chlorpromazine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00091	0.00333	CbGeAlD
Chlorpromazine—KCNH2—spinal cord—amyotrophic lateral sclerosis	0.000894	0.00327	CbGeAlD
Chlorpromazine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000877	0.00321	CbGeAlD
Chlorpromazine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00085	0.00311	CbGeAlD
Chlorpromazine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000847	0.0031	CbGeAlD
Chlorpromazine—CALM2—nervous system—amyotrophic lateral sclerosis	0.000832	0.00305	CbGeAlD
Chlorpromazine—CALM1—nervous system—amyotrophic lateral sclerosis	0.000828	0.00303	CbGeAlD
Chlorpromazine—BCHE—spinal cord—amyotrophic lateral sclerosis	0.000823	0.00301	CbGeAlD
Chlorpromazine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.000818	0.003	CbGeAlD
Chlorpromazine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.000815	0.00298	CbGeAlD
Chlorpromazine—CALM3—brain—amyotrophic lateral sclerosis	0.00081	0.00296	CbGeAlD
Chlorpromazine—HTR7—nervous system—amyotrophic lateral sclerosis	0.000809	0.00296	CbGeAlD
Chlorpromazine—CALM2—central nervous system—amyotrophic lateral sclerosis	0.000801	0.00293	CbGeAlD
Chlorpromazine—CHRM2—brain—amyotrophic lateral sclerosis	0.000798	0.00292	CbGeAlD
Chlorpromazine—CALM1—central nervous system—amyotrophic lateral sclerosis	0.000797	0.00292	CbGeAlD
Chlorpromazine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000797	0.00292	CbGeAlD
Chlorpromazine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00079	0.00289	CbGeAlD
Chlorpromazine—SLC22A1—brain—amyotrophic lateral sclerosis	0.000783	0.00287	CbGeAlD
Chlorpromazine—CALM2—cerebellum—amyotrophic lateral sclerosis	0.000783	0.00287	CbGeAlD
Chlorpromazine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00078	0.00286	CbGeAlD
Chlorpromazine—CALM1—cerebellum—amyotrophic lateral sclerosis	0.000779	0.00285	CbGeAlD
Chlorpromazine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000779	0.00285	CbGeAlD
Chlorpromazine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000773	0.00283	CbGeAlD
Chlorpromazine—HTR2C—brain—amyotrophic lateral sclerosis	0.000769	0.00281	CbGeAlD
Chlorpromazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000765	0.0028	CbGeAlD
Chlorpromazine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000761	0.00279	CbGeAlD
Chlorpromazine—KCNH2—nervous system—amyotrophic lateral sclerosis	0.000754	0.00276	CbGeAlD
Chlorpromazine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000751	0.00275	CbGeAlD
Chlorpromazine—ALB—brain—amyotrophic lateral sclerosis	0.00075	0.00274	CbGeAlD
Chlorpromazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000736	0.0027	CbGeAlD
Chlorpromazine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000734	0.00269	CbGeAlD
Chlorpromazine—CHRM1—brain—amyotrophic lateral sclerosis	0.000726	0.00266	CbGeAlD
Chlorpromazine—KCNH2—central nervous system—amyotrophic lateral sclerosis	0.000726	0.00266	CbGeAlD
Chlorpromazine—HTR2B—brain—amyotrophic lateral sclerosis	0.000722	0.00264	CbGeAlD
Chlorpromazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00072	0.00263	CbGeAlD
Chlorpromazine—KCNH2—cerebellum—amyotrophic lateral sclerosis	0.000709	0.0026	CbGeAlD
Chlorpromazine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.000704	0.00258	CbGeAlD
Chlorpromazine—BCHE—nervous system—amyotrophic lateral sclerosis	0.000694	0.00254	CbGeAlD
Chlorpromazine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000689	0.00252	CbGeAlD
Chlorpromazine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000689	0.00252	CbGeAlD
Chlorpromazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000671	0.00246	CbGeAlD
Chlorpromazine—BCHE—central nervous system—amyotrophic lateral sclerosis	0.000668	0.00244	CbGeAlD
Chlorpromazine—BCHE—cerebellum—amyotrophic lateral sclerosis	0.000653	0.00239	CbGeAlD
Chlorpromazine—CHRM3—brain—amyotrophic lateral sclerosis	0.00065	0.00238	CbGeAlD
Chlorpromazine—HTR1A—brain—amyotrophic lateral sclerosis	0.000647	0.00237	CbGeAlD
Chlorpromazine—CALM2—brain—amyotrophic lateral sclerosis	0.000636	0.00233	CbGeAlD
Chlorpromazine—CALM1—brain—amyotrophic lateral sclerosis	0.000633	0.00232	CbGeAlD
Chlorpromazine—HTR7—brain—amyotrophic lateral sclerosis	0.000618	0.00226	CbGeAlD
Chlorpromazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000604	0.00221	CbGeAlD
Chlorpromazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000599	0.00219	CbGeAlD
Chlorpromazine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000596	0.00218	CbGeAlD
Chlorpromazine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000593	0.00217	CbGeAlD
Chlorpromazine—DRD2—brain—amyotrophic lateral sclerosis	0.000585	0.00214	CbGeAlD
Chlorpromazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000582	0.00213	CbGeAlD
Chlorpromazine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00058	0.00212	CbGeAlD
Chlorpromazine—KCNH2—brain—amyotrophic lateral sclerosis	0.000576	0.00211	CbGeAlD
Chlorpromazine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000571	0.00209	CbGeAlD
Chlorpromazine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000559	0.00205	CbGeAlD
Chlorpromazine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.000558	0.00204	CbGeAlD
Chlorpromazine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000546	0.002	CbGeAlD
Chlorpromazine—BCHE—brain—amyotrophic lateral sclerosis	0.00053	0.00194	CbGeAlD
Chlorpromazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000505	0.00185	CbGeAlD
Chlorpromazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000486	0.00178	CbGeAlD
Chlorpromazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000475	0.00174	CbGeAlD
Chlorpromazine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000467	0.00171	CbGeAlD
Chlorpromazine—HRH1—brain—amyotrophic lateral sclerosis	0.000462	0.00169	CbGeAlD
Chlorpromazine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00046	0.00168	CbGeAlD
Chlorpromazine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000454	0.00166	CbGeAlD
Chlorpromazine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00045	0.00165	CbGeAlD
Chlorpromazine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000444	0.00162	CbGeAlD
Chlorpromazine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000442	0.00162	CbGeAlD
Chlorpromazine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.00044	0.00161	CbGeAlD
Chlorpromazine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000432	0.00158	CbGeAlD
Chlorpromazine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000392	0.00144	CbGeAlD
Chlorpromazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000386	0.00141	CbGeAlD
Chlorpromazine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000351	0.00129	CbGeAlD
Chlorpromazine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000331	0.00121	CbGeAlD
Chlorpromazine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000318	0.00117	CbGeAlD
Chlorpromazine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000311	0.00114	CbGeAlD
Chlorpromazine—ABCB1—brain—amyotrophic lateral sclerosis	0.000253	0.000925	CbGeAlD
Chlorpromazine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.5e-05	9.33e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.47e-05	9.22e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.47e-05	9.22e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.45e-05	9.15e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.45e-05	9.13e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.44e-05	9.11e-05	CbGpPWpGaD
Chlorpromazine—ABCB11—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.44e-05	9.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.44e-05	9.1e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.44e-05	9.09e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.42e-05	9.01e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.41e-05	9.01e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.41e-05	9e-05	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.4e-05	8.96e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.38e-05	8.88e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.38e-05	8.86e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.37e-05	8.84e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	2.35e-05	8.77e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Immune System—C3—amyotrophic lateral sclerosis	2.33e-05	8.71e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.33e-05	8.68e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.3e-05	8.57e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.3e-05	8.57e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.28e-05	8.52e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.28e-05	8.5e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	8.46e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Immune System—C3—amyotrophic lateral sclerosis	2.26e-05	8.42e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Immune System—C3—amyotrophic lateral sclerosis	2.26e-05	8.42e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.25e-05	8.39e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.24e-05	8.35e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.24e-05	8.35e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.24e-05	8.34e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.24e-05	8.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.23e-05	8.31e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.22e-05	8.3e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.22e-05	8.29e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.19e-05	8.16e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.19e-05	8.16e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.18e-05	8.15e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.18e-05	8.15e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.18e-05	8.14e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.18e-05	8.12e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.17e-05	8.11e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.17e-05	8.09e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.16e-05	8.07e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.16e-05	8.07e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.16e-05	8.04e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.16e-05	8.04e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.15e-05	8.02e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.15e-05	8.02e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.15e-05	8.01e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.14e-05	7.99e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.12e-05	7.92e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.1e-05	7.85e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.09e-05	7.81e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.09e-05	7.8e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	7.8e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.06e-05	7.69e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	7.67e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.06e-05	7.67e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.05e-05	7.66e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.05e-05	7.66e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.05e-05	7.66e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.05e-05	7.63e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	7.62e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	7.61e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.02e-05	7.54e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.01e-05	7.51e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	2.01e-05	7.49e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—APOE—amyotrophic lateral sclerosis	2.01e-05	7.49e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2e-05	7.48e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2e-05	7.45e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.99e-05	7.43e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	7.37e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	7.37e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.96e-05	7.31e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.95e-05	7.27e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—APOE—amyotrophic lateral sclerosis	1.94e-05	7.24e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—APOE—amyotrophic lateral sclerosis	1.94e-05	7.24e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.93e-05	7.22e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.93e-05	7.2e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.92e-05	7.17e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.88e-05	7.02e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.87e-05	6.98e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.87e-05	6.96e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.86e-05	6.93e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.85e-05	6.91e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.85e-05	6.9e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.85e-05	6.89e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.84e-05	6.87e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.82e-05	6.78e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.82e-05	6.78e-05	CbGpPWpGaD
Chlorpromazine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.81e-05	6.77e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.81e-05	6.77e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.81e-05	6.75e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.8e-05	6.72e-05	CbGpPWpGaD
Chlorpromazine—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.79e-05	6.67e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.78e-05	6.66e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.78e-05	6.64e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.77e-05	6.59e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.76e-05	6.55e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.76e-05	6.55e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.72e-05	6.42e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.71e-05	6.37e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.69e-05	6.31e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.69e-05	6.31e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Hemostasis—TP53—amyotrophic lateral sclerosis	1.69e-05	6.31e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.69e-05	6.3e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.68e-05	6.28e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.68e-05	6.28e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.68e-05	6.28e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.68e-05	6.27e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—APOE—amyotrophic lateral sclerosis	1.68e-05	6.27e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.68e-05	6.26e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.66e-05	6.2e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.66e-05	6.18e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.65e-05	6.17e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	6.16e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	6.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Hemostasis—TP53—amyotrophic lateral sclerosis	1.63e-05	6.1e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Hemostasis—TP53—amyotrophic lateral sclerosis	1.63e-05	6.1e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-05	6.06e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-05	6.06e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.62e-05	6.04e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.61e-05	6.01e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.61e-05	6.01e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.59e-05	5.94e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.59e-05	5.93e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.59e-05	5.92e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.56e-05	5.84e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.55e-05	5.77e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.54e-05	5.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.54e-05	5.74e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.54e-05	5.73e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.52e-05	5.68e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.51e-05	5.63e-05	CbGpPWpGaD
Chlorpromazine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.49e-05	5.55e-05	CbGpPWpGaD
Chlorpromazine—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	1.46e-05	5.45e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	5.45e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	5.45e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.46e-05	5.44e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	1.45e-05	5.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.45e-05	5.42e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.45e-05	5.41e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.43e-05	5.33e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.43e-05	5.33e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.43e-05	5.32e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.42e-05	5.3e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.4e-05	5.24e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.4e-05	5.22e-05	CbGpPWpGaD
Chlorpromazine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.4e-05	5.22e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.4e-05	5.21e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.39e-05	5.19e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.39e-05	5.17e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.38e-05	5.13e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Disease—PTGS2—amyotrophic lateral sclerosis	1.37e-05	5.13e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.37e-05	5.12e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.37e-05	5.11e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.37e-05	5.11e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.37e-05	5.1e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	5.07e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	5.07e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.35e-05	5.04e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.34e-05	5.02e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Disease—PTGS2—amyotrophic lateral sclerosis	1.33e-05	4.96e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Disease—PTGS2—amyotrophic lateral sclerosis	1.33e-05	4.96e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.3e-05	4.86e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.27e-05	4.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.27e-05	4.75e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	4.71e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.25e-05	4.65e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.24e-05	4.63e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	4.61e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.23e-05	4.59e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.21e-05	4.53e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.2e-05	4.48e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.19e-05	4.43e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.18e-05	4.39e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.17e-05	4.37e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.16e-05	4.33e-05	CbGpPWpGaD
Chlorpromazine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.16e-05	4.32e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.15e-05	4.3e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.12e-05	4.19e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.12e-05	4.19e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.12e-05	4.18e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.11e-05	4.16e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.11e-05	4.16e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.09e-05	4.08e-05	CbGpPWpGaD
Chlorpromazine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.08e-05	4.03e-05	CbGpPWpGaD
Chlorpromazine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.08e-05	4.02e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.08e-05	4.02e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	4.01e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	3.99e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	3.98e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.06e-05	3.95e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.06e-05	3.94e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.05e-05	3.93e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.05e-05	3.92e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.04e-05	3.87e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.03e-05	3.86e-05	CbGpPWpGaD
Chlorpromazine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.03e-05	3.85e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.02e-05	3.8e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	3.79e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.02e-05	3.79e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.01e-05	3.78e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.01e-05	3.76e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.01e-05	3.76e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.99e-06	3.73e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.96e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.96e-06	3.72e-05	CbGpPWpGaD
Chlorpromazine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.85e-06	3.68e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.79e-06	3.65e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.53e-06	3.56e-05	CbGpPWpGaD
Chlorpromazine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.29e-06	3.47e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.28e-06	3.46e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.25e-06	3.45e-05	CbGpPWpGaD
Chlorpromazine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.17e-06	3.42e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.13e-06	3.41e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.11e-06	3.4e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.09e-06	3.39e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.06e-06	3.38e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.97e-06	3.35e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.94e-06	3.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.94e-06	3.33e-05	CbGpPWpGaD
Chlorpromazine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.72e-06	3.26e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.64e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.64e-06	3.23e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.44e-06	3.15e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.31e-06	3.1e-05	CbGpPWpGaD
Chlorpromazine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.22e-06	3.07e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.17e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.17e-06	3.05e-05	CbGpPWpGaD
Chlorpromazine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.99e-06	2.98e-05	CbGpPWpGaD
Chlorpromazine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.95e-06	2.97e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	7.84e-06	2.93e-05	CbGpPWpGaD
Chlorpromazine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.61e-06	2.84e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.58e-06	2.83e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.33e-06	2.74e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.33e-06	2.74e-05	CbGpPWpGaD
Chlorpromazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.01e-06	2.62e-05	CbGpPWpGaD
Chlorpromazine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.96e-06	2.6e-05	CbGpPWpGaD
Chlorpromazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.9e-06	2.58e-05	CbGpPWpGaD
Chlorpromazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.89e-06	2.57e-05	CbGpPWpGaD
Chlorpromazine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.86e-06	2.56e-05	CbGpPWpGaD
Chlorpromazine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.84e-06	2.55e-05	CbGpPWpGaD
Chlorpromazine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.78e-06	2.53e-05	CbGpPWpGaD
Chlorpromazine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.76e-06	2.52e-05	CbGpPWpGaD
Chlorpromazine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.28e-06	2.34e-05	CbGpPWpGaD
Chlorpromazine—CALM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.73e-06	2.14e-05	CbGpPWpGaD
Chlorpromazine—CALM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.54e-06	2.07e-05	CbGpPWpGaD
Chlorpromazine—CALM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.54e-06	2.07e-05	CbGpPWpGaD
Chlorpromazine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.38e-06	2.01e-05	CbGpPWpGaD
